Market Performance of Vuno (338220.KQ)
Vuno’s shares experienced a notable decline, falling 3.27 % during the 24‑hour period that concluded at 07:51 AM Central Europe on Monday, 26 November 2026. At the close, one share was priced at KRW 7,680 on the most frequently traded exchanges. With a circulating supply of approximately 14 million shares, the company’s market capitalisation stood at KRW 82.8 billion. The total value of trades in the last 24 hours was roughly KRW 273.4 million.
Contextualising the Decline
Since the close of the previous month, Vuno’s stock price has decreased by 13.34 %. Its 200‑day simple moving average is currently KRW 12,538.8, providing a benchmark against which recent movements can be compared. The stock’s most recent 52‑week high was KRW 28,350 (recorded on 1 December 2025), while the 52‑week low was KRW 4,235 (recorded on 17 September 2026), underscoring the volatility that has characterised the company’s recent performance.
Peer Movements in the 24‑Hour Window
| Stock | Symbol | Movement | Current Price | Market Capitalisation |
|---|---|---|---|---|
| Hana | 299030.KQ | Down 4.69 % | KRW 11,640 | KRW 99.2 billion |
| Kumho Electric | 001210.KS | Down 3.76 % | KRW 7,540 | KRW 98.1 billion |
| Prestige Biologics | 334970.KQ | Up 0.24 % | KRW 1,248 | KRW 98 billion |
| Go Element | 311320.KQ | Down 1.14 % | KRW 7,650 | KRW 98.5 billion |
The broader market context shows a mix of declines and modest gains across peers, with Hana and Kumho Electric experiencing sharper falls than Vuno, while Prestige Biologics recorded a slight uptick. Go Element, though also in decline, remains relatively stable and trades at a price‑earnings ratio of 13.52.
Company Background
Vuno, Inc. (South Korea) was incorporated on 26 February 2021. The company has positioned itself within the burgeoning artificial‑intelligence‑driven medical imaging sector, offering diagnostic solutions that aim to enhance clinical decision‑making. Its recent market performance reflects the heightened sensitivity of investors to valuation, profitability, and broader economic signals affecting technology‑enabled healthcare providers.
The information above reflects publicly available market data as of the close of trading on 26 November 2026. All figures are subject to change with subsequent market activity.